SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Claudia Kessler, Alexandra Greindl, Bettina Breuer, Udo Haberl, Andreas Rybka, Marco Emgenbroich, Hans-Georg Frank, Andy J.G. Pötgens, Erythropoietin mimetic compound AGEM400(HES) binds to the same receptor as erythropoietin but displays a different spectrum of activities, Cytokine, 2012, 57, 2, 226

    CrossRef

  2. 2
    Domenico Ribatti, International Review of Cell and Molecular Biology Volume 299, 2012,

    CrossRef

  3. 3
    Jolanta Szenajch, Gabriel Wcislo, Jee-Yeong Jeong, Cezary Szczylik, Laurie Feldman, The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010, 1806, 1, 82

    CrossRef

  4. 4
    Francesca Merchionne, Franco Dammacco, Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives, British Journal of Haematology, 2009, 146, 2
  5. 5
    Domenico Ribatti, Erythropoietin and cancer, a double-edged sword, Leukemia Research, 2009, 33, 1, 1

    CrossRef

  6. 6
    J. H. Lin, E. J. Kim, A. Bansal, J. Seykora, S. K. Richardson, X.-Y. Cha, S. Zafar, S. Nasta, M. Wysocka, B. Benoit, A. H. Rook, S. S. Fakharzadeh, Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-  receptor, Blood, 2008, 112, 6, 2484

    CrossRef

  7. 7
    Wolfgang Jelkmann, Julia Bohlius, Michael Hallek, Arthur J. Sytkowski, The erythropoietin receptor in normal and cancer tissues, Critical Reviews in Oncology/Hematology, 2008, 67, 1, 39

    CrossRef

  8. 8
    C. Anthony Blau, Erythropoietin in Cancer: Presumption of Innocence?, STEM CELLS, 2007, 25, 8